Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Renal Cell Carcinoma, Prostate Cancer

Daniel George

MD

🏢Duke Cancer Institute🌐USA

Professor of Medicine and Surgery

58
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Daniel George at Duke Cancer Institute has made contributions to both RCC and prostate cancer research. His work on mTOR inhibitors (everolimus) in RCC and on various combination approaches has contributed to understanding treatment sequencing. His dual expertise in prostate and kidney cancers reflects the shared biology and overlapping therapeutic strategies across genitourinary oncology.

Share:

🧪Research Fields 研究领域

renal cell carcinoma
prostate cancer
abiraterone
everolimus RCC
VEGFR inhibitors

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 Daniel George 的研究动态

Follow Daniel George's research updates

留下邮箱,当我们发布与 Daniel George(Duke Cancer Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment